Form 8-K

8-K — Moleculin Biotech, Inc.

Accession: 0001437749-26-032762

Filed: 2026-10-16

Period: 2026-10-16

CIK: 0001659617

SIC: 2834 (PHARMACEUTICAL PREPARATIONS)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — mbrx20261015_8k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (ex_1026331_source.htm)

GRAPHIC (logobig.jpg)

GRAPHIC (slide01.jpg)

GRAPHIC (slide02.jpg)

GRAPHIC (slide03.jpg)

GRAPHIC (slide04.jpg)

GRAPHIC (slide05.jpg)

GRAPHIC (slide06.jpg)

GRAPHIC (slide07.jpg)

GRAPHIC (slide08.jpg)

GRAPHIC (slide09.jpg)

GRAPHIC (slide10.jpg)

GRAPHIC (slide11.jpg)

GRAPHIC (slide12.jpg)

GRAPHIC (slide13.jpg)

GRAPHIC (slide14.jpg)

GRAPHIC (slide15.jpg)

GRAPHIC (slide16.jpg)

GRAPHIC (slide17.jpg)

GRAPHIC (slide18.jpg)

GRAPHIC (slide19.jpg)

GRAPHIC (slide20.jpg)

GRAPHIC (slide21.jpg)

GRAPHIC (slide22.jpg)

GRAPHIC (slide23.jpg)

GRAPHIC (slide24.jpg)

GRAPHIC (slide25.jpg)

GRAPHIC (slide26.jpg)

GRAPHIC (slide27.jpg)

GRAPHIC (slide28.jpg)

GRAPHIC (slide29.jpg)

GRAPHIC (slide30.jpg)

GRAPHIC (slide31.jpg)

GRAPHIC (slide32.jpg)

GRAPHIC (slide33.jpg)

GRAPHIC (slide34.jpg)

GRAPHIC (slide35.jpg)

GRAPHIC (slide36.jpg)

GRAPHIC (slide37.jpg)

GRAPHIC (slide38.jpg)

GRAPHIC (slide39.jpg)

GRAPHIC (slide40.jpg)

GRAPHIC (slide41.jpg)

GRAPHIC (slide42.jpg)

GRAPHIC (slide43.jpg)

GRAPHIC (slide44.jpg)

GRAPHIC (slide45.jpg)

GRAPHIC (slide46.jpg)

GRAPHIC (slide47.jpg)

GRAPHIC (slide48.jpg)

GRAPHIC (slide49.jpg)

GRAPHIC (slide50.jpg)

GRAPHIC (slide51.jpg)

GRAPHIC (slide52.jpg)

GRAPHIC (slide53.jpg)

GRAPHIC (slide54.jpg)

GRAPHIC (slide55.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: mbrx20261015_8k.htm · Sequence: 1

mbrx20261015_8k.htm

false

0001659617

2026-10-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 16, 2026

MOLECULIN BIOTECH, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-37758

47-4671997

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission File No.)

(I.R.S. Employer Identification No.)

5300 Memorial Drive, Suite 950, Houston, TX 77007

(Address of principal executive offices and zip code)

(713) 300-5160

(Registrant’s telephone number, including area code)

(Former name or former address, if changed from last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol (s)

Name of each exchange on which registered

Common Stock, par value $.001 per share

MBRX

The NASDAQ Stock Market LLC

Item 7.01

Regulation FD Disclosure

On October 16, 2026, Moleculin Biotech, Inc. (the “Company”) is using the attached presentation for its corporate presentation posted on the Company’s website and is set forth as Exhibit 99.1 herein.

The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (“Securities Act”), unless specifically identified therein as being incorporated by reference.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.

Description

99.1

Investor Presentation dated October 16, 2026

104

Cover page Interactive Data File (formatted as Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MOLECULIN BIOTECH, INC.

Date:

October 16, 2026

By:

/s/ Jonathan P. Foster

Jonathan P. Foster

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: ex_1026331_source.htm · Sequence: 2

ex_1026331_source.htm

Exhibit 99.1

GRAPHIC

Filename: logobig.jpg · Sequence: 7

Binary file (19220 bytes)

Download logobig.jpg

GRAPHIC

Filename: slide01.jpg · Sequence: 8

Binary file (230842 bytes)

Download slide01.jpg

GRAPHIC

Filename: slide02.jpg · Sequence: 9

Binary file (192408 bytes)

Download slide02.jpg

GRAPHIC

Filename: slide03.jpg · Sequence: 10

Binary file (189988 bytes)

Download slide03.jpg

GRAPHIC

Filename: slide04.jpg · Sequence: 11

Binary file (126156 bytes)

Download slide04.jpg

GRAPHIC

Filename: slide05.jpg · Sequence: 12

Binary file (97416 bytes)

Download slide05.jpg

GRAPHIC

Filename: slide06.jpg · Sequence: 13

Binary file (135814 bytes)

Download slide06.jpg

GRAPHIC

Filename: slide07.jpg · Sequence: 14

Binary file (160542 bytes)

Download slide07.jpg

GRAPHIC

Filename: slide08.jpg · Sequence: 15

Binary file (143968 bytes)

Download slide08.jpg

GRAPHIC

Filename: slide09.jpg · Sequence: 16

Binary file (146905 bytes)

Download slide09.jpg

GRAPHIC

Filename: slide10.jpg · Sequence: 17

Binary file (181335 bytes)

Download slide10.jpg

GRAPHIC

Filename: slide11.jpg · Sequence: 18

Binary file (173970 bytes)

Download slide11.jpg

GRAPHIC

Filename: slide12.jpg · Sequence: 19

Binary file (180677 bytes)

Download slide12.jpg

GRAPHIC

Filename: slide13.jpg · Sequence: 20

Binary file (105786 bytes)

Download slide13.jpg

GRAPHIC

Filename: slide14.jpg · Sequence: 21

Binary file (99225 bytes)

Download slide14.jpg

GRAPHIC

Filename: slide15.jpg · Sequence: 22

Binary file (111256 bytes)

Download slide15.jpg

GRAPHIC

Filename: slide16.jpg · Sequence: 23

Binary file (96807 bytes)

Download slide16.jpg

GRAPHIC

Filename: slide17.jpg · Sequence: 24

Binary file (215942 bytes)

Download slide17.jpg

GRAPHIC

Filename: slide18.jpg · Sequence: 25

Binary file (175216 bytes)

Download slide18.jpg

GRAPHIC

Filename: slide19.jpg · Sequence: 26

Binary file (133168 bytes)

Download slide19.jpg

GRAPHIC

Filename: slide20.jpg · Sequence: 27

Binary file (138099 bytes)

Download slide20.jpg

GRAPHIC

Filename: slide21.jpg · Sequence: 28

Binary file (154541 bytes)

Download slide21.jpg

GRAPHIC

Filename: slide22.jpg · Sequence: 29

Binary file (101790 bytes)

Download slide22.jpg

GRAPHIC

Filename: slide23.jpg · Sequence: 30

Binary file (147764 bytes)

Download slide23.jpg

GRAPHIC

Filename: slide24.jpg · Sequence: 31

Binary file (133059 bytes)

Download slide24.jpg

GRAPHIC

Filename: slide25.jpg · Sequence: 32

Binary file (107995 bytes)

Download slide25.jpg

GRAPHIC

Filename: slide26.jpg · Sequence: 33

Binary file (138556 bytes)

Download slide26.jpg

GRAPHIC

Filename: slide27.jpg · Sequence: 34

Binary file (149166 bytes)

Download slide27.jpg

GRAPHIC

Filename: slide28.jpg · Sequence: 35

Binary file (130013 bytes)

Download slide28.jpg

GRAPHIC

Filename: slide29.jpg · Sequence: 36

Binary file (134884 bytes)

Download slide29.jpg

GRAPHIC

Filename: slide30.jpg · Sequence: 37

Binary file (89900 bytes)

Download slide30.jpg

GRAPHIC

Filename: slide31.jpg · Sequence: 38

Binary file (123856 bytes)

Download slide31.jpg

GRAPHIC

Filename: slide32.jpg · Sequence: 39

Binary file (124076 bytes)

Download slide32.jpg

GRAPHIC

Filename: slide33.jpg · Sequence: 40

Binary file (159827 bytes)

Download slide33.jpg

GRAPHIC

Filename: slide34.jpg · Sequence: 41

Binary file (115018 bytes)

Download slide34.jpg

GRAPHIC

Filename: slide35.jpg · Sequence: 42

Binary file (143446 bytes)

Download slide35.jpg

GRAPHIC

Filename: slide36.jpg · Sequence: 43

Binary file (107776 bytes)

Download slide36.jpg

GRAPHIC

Filename: slide37.jpg · Sequence: 44

Binary file (159856 bytes)

Download slide37.jpg

GRAPHIC

Filename: slide38.jpg · Sequence: 45

Binary file (117522 bytes)

Download slide38.jpg

GRAPHIC

Filename: slide39.jpg · Sequence: 46

Binary file (107809 bytes)

Download slide39.jpg

GRAPHIC

Filename: slide40.jpg · Sequence: 47

Binary file (136822 bytes)

Download slide40.jpg

GRAPHIC

Filename: slide41.jpg · Sequence: 48

Binary file (107789 bytes)

Download slide41.jpg

GRAPHIC

Filename: slide42.jpg · Sequence: 49

Binary file (113108 bytes)

Download slide42.jpg

GRAPHIC

Filename: slide43.jpg · Sequence: 50

Binary file (207475 bytes)

Download slide43.jpg

GRAPHIC

Filename: slide44.jpg · Sequence: 51

Binary file (115098 bytes)

Download slide44.jpg

GRAPHIC

Filename: slide45.jpg · Sequence: 52

Binary file (121623 bytes)

Download slide45.jpg

GRAPHIC

Filename: slide46.jpg · Sequence: 53

Binary file (111083 bytes)

Download slide46.jpg

GRAPHIC

Filename: slide47.jpg · Sequence: 54

Binary file (145013 bytes)

Download slide47.jpg

GRAPHIC

Filename: slide48.jpg · Sequence: 55

Binary file (148174 bytes)

Download slide48.jpg

GRAPHIC

Filename: slide49.jpg · Sequence: 56

Binary file (131998 bytes)

Download slide49.jpg

GRAPHIC

Filename: slide50.jpg · Sequence: 57

Binary file (147550 bytes)

Download slide50.jpg

GRAPHIC

Filename: slide51.jpg · Sequence: 58

Binary file (126296 bytes)

Download slide51.jpg

GRAPHIC

Filename: slide52.jpg · Sequence: 59

Binary file (118525 bytes)

Download slide52.jpg

GRAPHIC

Filename: slide53.jpg · Sequence: 60

Binary file (114660 bytes)

Download slide53.jpg

GRAPHIC

Filename: slide54.jpg · Sequence: 61

Binary file (145130 bytes)

Download slide54.jpg

GRAPHIC

Filename: slide55.jpg · Sequence: 62

Binary file (96169 bytes)

Download slide55.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 64

v3.26.3

Document And Entity Information

Oct. 16, 2026

Document Information [Line Items]

Entity, Registrant Name

MOLECULIN BIOTECH, INC.

Document, Type

8-K

Document, Period End Date

Oct. 16, 2026

Entity, Incorporation, State or Country Code

Entity, File Number

001-37758

Entity, Tax Identification Number

47-4671997

Entity, Address, Address Line One

5300 Memorial Drive

Entity, Address, Address Line Two

Suite 950

Entity, Address, City or Town

Houston

Entity, Address, State or Province

Entity, Address, Postal Zip Code

77007

City Area Code

713

Local Phone Number

300-5160

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity, Emerging Growth Company

false

Title of 12(b) Security

Common Stock

Trading Symbol

MBRX

Security Exchange Name

NASDAQ

Amendment Flag

false

Entity, Central Index Key

0001659617

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration